Skip to content
Contact Us
Join Us
Linkedin
Submit Search
Search Icon
Our Company
About Us
Governance
Our Culture
Our Commitment
Diabetic Macular Edema
I OCS-01
Post Ocular Surgery
I OCS-01
Dry Eye Disease
I OCS-02
Uveitis
׀ OCS-02
Acute Optic Neuritis
I OCS-05
Our Innovation
Pipeline
Clinical Trials
Science
Publications
Investors and Media
Column
Overview
Stock Information
News Releases
Events & Presentations
Column
Corporate Governance
SEC Filings
Public Disclosures
Investor FAQs
Investor Resources
Our Company
About Us
Governance
Our Culture
Our Commitment
Diabetic Macular Edema
I OCS-01
Post Ocular Surgery
I OCS-01
Dry Eye Disease
I OCS-02
Uveitis
׀ OCS-02
Acute Optic Neuritis
I OCS-05
Our Innovation
Pipeline
Clinical Trials
Science
Publications
Investors and Media
Column
Overview
Stock Information
News Releases
Events & Presentations
Column
Corporate Governance
SEC Filings
Public Disclosures
Investor FAQs
Investor Resources
Contact Us
Join Us
Linkedin
Submit Search
Search Icon
Search
Search
Clinical Trials
Explore our numerous clinical trials across Oculis’ rich pipeline
Diabetic Macular Edema
Explore OCS-01 Clinical Trials in DME
ONGOING
/
RECRUITING
Phase 3 Stage 2
:
Clinical Trial Evaluating The Efficacy and Safety of OCS-01 in DME (DIAMOND-1)
CLINICALTRIALS.GOV
ONGOING
/
RECRUITING
Phase 3
:
Clinical Trial Evaluating The Efficacy and Safety of OCS-01 in DME (DIAMOND-2)
CLINICALTRIALS.GOV
COMPLETED
Phase 3
:
Stage 1 Results of OCS-01 Eye Drops for the Treatment of DME
VIEW RESULTS
COMPLETED
Phase 2
:
Efficacy and Safety of Dexamethasone Nanoparticles (OCS-01) Eye Drops in Diabetic Macular Edema
CLINICALTRIALS.GOV
Post Ocular Surgery
Explore OCS-01 Clinical Trials in Post Ocular Surgery
COMPLETED
Phase 3
:
Results of OCS-01 Eye Drops for the Treatment of Inflammation and Pain following Cataract Surgery (OPTIMIZE-1)
VIEW RESULTS
COMPLETED
Phase 2
:
OCS-01 in Treating Inflammation and Pain in Post-Cataract Patients (SKYGGN)
CLINICALTRIALS.GOV
Dry Eye Disease
Explore OCS-02 Clinical Trials in Dry Eye Disease
COMPLETED
Phase 2
:
Safety and Efficacy of OCS-02 (Licaminlimab) Ophthalmic Suspension for the Treatment of Dry Eye Disease (RELIEF)
View results
COMPLETED
Phase 2
:
OCS-02 (LME636) in the Relief of Persistent Ocular Discomfort in Patients With Severe Dry Eye Disease
CLINICALTRIALS.GOV
Uveitis
Explore OCS-02 Clinical Trials in Uveitis
COMPLETED
Phase 2
:
Proof of Concept Study to Evaluate Safety and Efficacy of OCS-02 (LME636) in the Treatment of Acute Anterior Uveitis
CLINICALTRIALS.GOV
Acute Optic Neuritis
Explore OCS-05 Clinical Trials in Acute Optic Neuritis
RECRUITMENT COMPLETED
Phase 2
:
OCS-05 in Patients With Acute Optic Neuritis (ACUITY)
CLINICALTRIALS.GOV
Rethinking Ophthalmology
News
Events
Pipeline